Seres Therapeutics, Inc. Contracts & Agreements

Mutual Termination of License Agreement dated September 30, 2024, by and between Seres Therapeutics, Inc. and NHSc Rx License GmbH (Filed With SEC on November 13, 2024)

Mutual Termination of Collaboration and License Agreement dated September 30, 2024, by and between Seres Therapeutics, Inc. and Société des Produits Nestlé S.A (Filed With SEC on November 13, 2024)

Securities Purchase Agreement, dated September 30, 2024, by and between Seres Therapeutics, Inc. and Société des Produits Nestlé S.A (Filed With SEC on October 1, 2024)

Transition Services Agreement, dated September 30, 2024, by and between Seres Therapeutics, Inc. and Nestlé Enterprises S.A (Filed With SEC on October 1, 2024)

Cross-License Agreement, dated September 30, 2024, by and between Seres Therapeutics, Inc. and Société des Produits Nestlé S.A (Filed With SEC on October 1, 2024)

Employee Support Agreement, dated September 30, 2024, by and between Seres Therapeutics, Inc. and Société des Produits Nestlé S.A (Filed With SEC on October 1, 2024)

Assignment and Termination of Manufacturing Agreement, dated August 5, 2024, by and between Seres and Bacthera AG (Filed With SEC on August 13, 2024)

Asset Purchase Agreement, dated August 5, 2024, by and between Seres Therapeutics, Inc. and Socit des Produits Nestl S.A (Filed With SEC on August 6, 2024)

Form of Securities Purchase Agreement, by and between Seres Therapeutics, Inc. and Socit des Produits Nestl S.A (Filed With SEC on August 6, 2024)

Form of Transition Services Agreement, by and between Seres Therapeutics, Inc. and Socit des Produits Nestl S.A (Filed With SEC on August 6, 2024)

Form of Cross-License Agreement, by and between Seres Therapeutics, Inc. and Socit des Produits Nestl S.A (Filed With SEC on August 6, 2024)

Form of Employee Support Agreement, by and between Seres Therapeutics, Inc. and Socit des Produits Nestl S.A (Filed With SEC on August 6, 2024)

Employment Agreement, dated February 24, 2024, by and between the Registrant and Marella Thorell (Filed With SEC on May 8, 2024)

Non-Employee Director Compensation Program (Filed With SEC on May 8, 2024)

Separation Agreement and Release, dated March 15, 2024, by and between the Registrant and David Arkowitz (Filed With SEC on May 8, 2024)

Advisory Agreement, dated March 15, 2024, by and between the Registrant and David Arkowitz (Filed With SEC on May 8, 2024)

Supply Agreement, dated September 15, 2015, by and between the Registrant and GenIbet BioPharmaceuticals, SA, as amended (Filed With SEC on May 8, 2024)

Form of Performance Option Agreement under the 2015 Incentive Award Plan (Filed With SEC on May 8, 2024)

Description of Capital Stock (Filed With SEC on March 5, 2024)

Lease, dated September 22, 2021, by and between the Registrant and HCP/KING 101 CPD LLC (Filed With SEC on March 5, 2024)

Supply Agreement, dated September 15, 2015, by and between Registrant and GenIbet BioPharmaceuticals, SA, as amended (Filed With SEC on March 5, 2024)

Form of Warrant, dated April 27, 2023, issued by the Company to the Lenders, together with a schedule of warrant holders (Filed With SEC on April 27, 2023)

Credit Agreement and Guaranty, dated April 27, 2023, among Seres Therapeutics, Inc., a Delaware corporation, as the borrower, the subsidiary guarantors from time to time party... (Filed With SEC on April 27, 2023)

First Amendment to Lease, dated December 9, 2022, by and between Seres Therapeutics, Inc. and BMR-Sidney Research Campus, LLC (f/k/a BMR 200-Sidney Street LLC) (Filed With SEC on December 14, 2022)

Supply Agreement, dated September 15, 2015, by and between Seres Therapeutics, Inc. and GenIbet BioPharmaceuticals, SA, as amended (Filed With SEC on November 2, 2022)

Non-Employee Director Compensation Program (Filed With SEC on August 3, 2022)

Form of Non-Affiliate Purchase Agreement (Filed With SEC on June 30, 2022)

Form of Affiliate Purchase Agreement (Filed With SEC on June 30, 2022)

Placement Agency Agreement, dated June 29, 2022, by and between Seres Therapeutics, Inc. and J.P. Morgan Securities LLC (Filed With SEC on June 30, 2022)

Amendment No. 1 to License Agreement, dated March 24, 2022, by and between the Registrant and NHSc Pharma Partners (Filed With SEC on May 4, 2022)

Employment Agreement, dated January 5, 2022, by and between the Registrant and Paula Cloghessy (Filed With SEC on March 1, 2022)

Second Amendment to Loan and Security Agreement, dated February 24, 2022 by and between the Registrant and Hercules Capital, Inc (Filed With SEC on March 1, 2022)

Long Term Manufacturing Agreement, dated November 8, 2021, by and between the Registrant and BacThera AG (Filed With SEC on March 1, 2022)

License Agreement, dated July 1, 2021, by and between the Registrant and NHSc Pharma Partners (Filed With SEC on November 10, 2021)

Letter Agreement, dated November 4, 2021, by and between the Registrant and David S. Ege, Ph.D (Filed With SEC on November 10, 2021)

Non-Employee Director Compensation Program (Filed With SEC on November 10, 2021)

Amended and Restated Employment Agreement, dated as of January 29, 2021, by and between the Registrant and David S. Ege, Ph.D (Filed With SEC on August 3, 2021)

Non-Employee Director Compensation Program (Filed With SEC on August 3, 2021)

Sales Agreement, dated as of May 21, 2021, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on May 21, 2021)

Employment Agreement, dated May 10, 2021, by and between Seres Therapeutics, Inc. and David Arkowitz (Filed With SEC on May 20, 2021)

Description of Capital Stock (Filed With SEC on March 2, 2021)

2015 Incentive Award Plan and forms of award agreements thereunder (Filed With SEC on March 2, 2021)

Non-Employee Director Compensation Program (Filed With SEC on March 2, 2021)

Amended and Restated Employment Agreement, dated January 29, 2021, by and between the Registrant and David S. Ege, Ph.D (Filed With SEC on March 2, 2021)

Amended and Restated Employment Agreement, dated January 29, 2021, by and between the Registrant and Teresa L. Young (Filed With SEC on March 2, 2021)

Amended and Restated Employment Agreement, dated January 29, 2021, by and between the Registrant and Lisa von Moltke, M.D (Filed With SEC on March 2, 2021)

Amended and Restated Employment Agreement, dated as of January 29, 2021, between Seres Therapeutics, Inc. and Eric D. Shaff (Filed With SEC on February 1, 2021)

Amended and Restated Employment Agreement, dated as of January 29, 2021, between Seres Therapeutics, Inc. and Thomas J. DesRosier (Filed With SEC on February 1, 2021)

Second Amended and Restated Employment Agreement, dated as of January 29, 2021, between Seres Therapeutics, Inc. and Matthew R. Henn, Ph.D (Filed With SEC on February 1, 2021)

Employment Agreement, dated October 13, 2020, by and between the Registrant and David S Ege (Filed With SEC on November 9, 2020)

Underwriting Agreement, dated August 12, 2020, between the Company and Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several underwriters named therein (Filed With SEC on August 14, 2020)

Securities Purchase Agreement, dated August 12, 2020, between the Company and Socit des Produits Nestl S.A (Filed With SEC on August 14, 2020)

Employment Agreement, dated June 8, 2020, by and between the Registrant and Teresa L. Young (Filed With SEC on July 28, 2020)

First Amendment to Loan and Security Agreement by and between the Registrant and Hercules Capital, Inc., dated April 16, 2020 (Filed With SEC on July 28, 2020)

Letter Amendment to Employment Agreement, dated April 8, 2020, by and between the Registrant and John Aunins (Filed With SEC on May 7, 2020)

Employment Agreement, dated April 2, 2020, by and between the Registrant and Lisa von Moltke, M.D (Filed With SEC on May 7, 2020)

Sales Agreement, dated as of March 18, 2020, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on March 18, 2020)

Description of Capital Stock (Filed With SEC on March 2, 2020)

Advisory Agreement, dated December 12, 2019, by and between the Registrant and Roger Pomerantz (Filed With SEC on March 2, 2020)

Sales Agreement, dated as of November 27, 2019, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on November 27, 2019)

Employment Agreement, dated July 11, 2019, by and between the Registrant and Marcus Chapman (Filed With SEC on November 5, 2019)

Sublease Agreement dated July 1, 2019, by and between the Registrant and Flagship VL56, Inc. and Flagship VL58, Inc (Filed With SEC on November 5, 2019)

Loan and Security Agreement dated October 29, 2019 between Seres Therapeutics, Inc. and Hercules Capital, Inc (Filed With SEC on November 4, 2019)

Amended and Restated Employment Agreement, dated March 25, 2019, by and between the Registrant and Matthew Henn (Filed With SEC on August 6, 2019)

Underwriting Agreement, dated June 13, 2019, between the Company and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on June 14, 2019)

Research Collaboration and Option Agreement, dated March 11, 2019, by and between the Registrant and MedImmune, LLC (Filed With SEC on May 2, 2019)

Amendment No 1 to the Collaboration and License Agreement, dated August 10, 2016, by and between the Registrant and Nestec Ltd (Filed With SEC on March 6, 2019)

Letter Agreement dated October 30, 2018, by and between the Registrant and Nestec Ltd (Filed With SEC on March 6, 2019)

Separation Agreement and Release, dated as of January 14, 2019, by and between Seres Therapeutics, Inc. and Roger Pomerantz (Filed With SEC on January 15, 2019)

Amended and Restated Employment Agreement, dated as of January 14, 2019, by and between Seres Therapeutics, Inc. and Eric D. Shaff (Filed With SEC on January 15, 2019)

Separation Agreement and Release by and between the Company and Dr. Michele Trucksis, effective November 16, 2018 (Filed With SEC on November 21, 2018)

Consulting Agreement by and between the Company and Dr. Michele Trucksis, dated November 16, 2018 (Filed With SEC on November 21, 2018)

Employment Agreement dated October 5, 2018, by and between the Registrant and Kevin Horgan, M.B (Filed With SEC on November 8, 2018)

Second Amendment to Employment Agreement, dated March 7, 2018, by and between the Registrant and Roger J. Pomerantz (Filed With SEC on March 8, 2018)

Amendment to Employment Agreement, dated March 7, 2018 by and between the Registrant and Eric. D. Shaff (Filed With SEC on March 8, 2018)

Amendment to Employment Agreement, dated March 7, 2018 by and between the Registrant and David N. Cook (Filed With SEC on March 8, 2018)

Amendment to Employment Agreement, dated March 7, 2018 by and between the Registrant and Michele Trucksis (Filed With SEC on March 8, 2018)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on August 11, 2016)

COLLABORATION AND LICENSE AGREEMENT between NESTEC LTD. and SERES THERAPEUTICS, INC. (Filed With SEC on May 16, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on May 16, 2016)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on February 4, 2016)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2015)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2015)

Seres Health,Inc. / 161 First Street Suite 1A / Cambridge, MA 02142 (Filed With SEC on June 24, 2015)

Seres Therapeutics, Inc. Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on June 16, 2015)

SERES THERAPEUTICS, INC. (Filed With SEC on June 16, 2015)

WARRANT TO PURCHASE STOCK (Filed With SEC on June 16, 2015)

SERES THERAPEUTICS, INC. 2015 INCENTIVE AWARD PLAN (Filed With SEC on June 16, 2015)

SERES THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 16, 2015)

SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (Filed With SEC on June 16, 2015)

SERES THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on June 16, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on June 16, 2015)

AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on May 27, 2015)

WARRANT TO PURCHASE STOCK (Filed With SEC on May 27, 2015)

Seres Health, Inc. Common Stock Purchase Warrant (Filed With SEC on May 27, 2015)

SERES HEALTH, INC. 2012 STOCKINCENTIVE PLAN (Filed With SEC on May 27, 2015)

SERES THERAPEUTICS, INC. 2015 INCENTIVE AWARD PLAN (Filed With SEC on May 27, 2015)

SERES THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 27, 2015)

SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (Filed With SEC on May 27, 2015)

FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on May 27, 2015)

LEASE AGREEMENT (Filed With SEC on May 27, 2015)

SERIES D PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on May 27, 2015)

Category

Industry

Companies

Contracts

Seres Therapeutics, Inc. Contracts & Agreements